Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00012909 · ClinicalTrials.gov registry record · NA
Development and Evaluation of a Hormone Replacement Therapy Decision-Aid
A NA study of Menopause and Hormone Replacement Therapy, sponsored by US Department of Veterans Affairs.
- Completed
- Registry status
- NA
- Development phase
- 150
- Enrollment target
- 3
- Study locations
NCT00012909: Completed NA study of Menopause and Hormone Replacement Therapy, sponsored by US Department of Veterans Affairs.
NCT00012909 is a NA study of Menopause and Hormone Replacement Therapy that has completed, run by US Department of Veterans Affairs. The registered enrollment target is 150 participants, below the 9,391-participant average among 54 other Menopause trials with a reported enrollment target (98% lower). The trial reports 3 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00012909, a NA study of Menopause and Hormone Replacement Therapy, has completed, sponsored by US Department of Veterans Affairs.
- COMPLETED
- Registry status
- NA
- Development phase
- 150 participants
- Enrollment target
- 3
- Study locations
Study Summary
The decision regarding the use of post-menopausal estrogen hormone replacement therapy (HT) is complex because patients must balance the short and long-term risks and benefits. Information from new and important clinical trials must also be considered. The purpose of this research is to develop and evaluate the efficacy of a HT CD-ROM decision-aid in improving the decision making process for women considering the use of estrogen HT.
Conditions Studied
Interventions
- BEHAVIORAL Hormone Replacement Therapy Decision-Aid
Study Locations (3)
Illinois
- Edward Hines Jr. VA Hospital, Hines, IL - Hines
Pennsylvania
- Clement J. Zablocki VA Medical Center, Milwaukee, WI - Milwaukee
Wisconsin
- William S. Middleton Memorial Veterans Hospital, Madison, WI - Madison
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Est. Completion | 2004-03 |
| Phase | NA |
What the finished NCT00012909 record still lists
NCT00012909 is an interventional study that assigns participants to a tested intervention. The registered 150 participants enrollment target is mid-sized for trials with a published cap, below the 9,391-participant average among 54 other Menopause trials with a reported enrollment target (98% lower).
The record links to 2 conditions, with Menopause appearing as the primary indexed condition, and to 1 intervention - of which Hormone Replacement Therapy Decision-Aid is the first listed.
NCT00012909 reports a single indexed study location in Illinois, Pennsylvania, Wisconsin.
Frequently Asked Questions
What is clinical trial NCT00012909 about?
NCT00012909 is a clinical study titled "Development and Evaluation of a Hormone Replacement Therapy Decision-Aid". The decision regarding the use of post-menopausal estrogen hormone replacement therapy (HT) is complex because patients must balance the short and long-term risks and benefits. Information from new and important clinical trials must also be considered. The purpose of this research is to develop and ...
What is the current status of trial NCT00012909?
This trial is currently completed. It is a NA study. The enrollment target is 150 participants. Estimated completion is 2004-03.
What conditions does trial NCT00012909 study?
This clinical trial studies the following conditions: Menopause, Hormone Replacement Therapy.
What interventions are being tested in trial NCT00012909?
The interventions under investigation include: Hormone Replacement Therapy Decision-Aid (BEHAVIORAL).
Who is sponsoring clinical trial NCT00012909?
This trial is sponsored by US Department of Veterans Affairs, which has 632 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00012909 being conducted?
This trial has 3 study locations across Illinois, Pennsylvania, Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Menopause
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00012909's enrollment target sits among peer trials
150 12th of 54 higher than 42 of 54 other Menopause trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Menopause trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Hot Flashes and Neurovascular Function in Women
RECRUITING · NA
-
Efficacy and Safety of Shatavari for Treatment of Menopausal Symptoms in Women: A Randomized, Double-blind, Three-arm, Parallel, Placebo-controlled Study
RECRUITING · NA
-
Improving Sympathetic Activity, Hot Flashes, and Sleep in Midlife Women Using Inspiratory Muscle Strength Training
RECRUITING · NA
-
Exercise Training Intensity and Nitrate Supplementation in Post-Menopausal Females
RECRUITING · NA
-
Depression, Aging, Stress and Heart Health Study
RECRUITING · NA
-
Choline Dose Ranging in Postmenopausal Women
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00412594 · 150 participants · Phase 2
Cladribine and Rituximab in Treating Patients With Hairy Cell Leukemia
- NCT01484730 · 150 participants
A Pilot Study to Evaluate Multi-Spectral and Laser Speckle Imaging and Multiphoton Microscopy During Vascular Occlusion
- NCT01985919 · 150 participants
Protocol for Facilitating the Acquisition of Research Bone Marrow and Blood Samples
- NCT02016248 · 150 participants · NA
SBRT Boost for Unfavorable Prostate Cancer'